How far would you go to get an aphrodisiac effect?
Biomedicine & Biotech
Oxytocin-deficient animals point to deep links between social behavior and the need to keep warm.
Platelet-rich plasma is a growing part of "regenerative" medicine. It's natural, easily applied and a profit center for companies and physicians. But what remains unclear is whether its use is beneficial to patients.
One wonders how the anti-GMO movement could oppose something like this. But given its hostility to Golden Rice, which has been genetically modified to contain a vitamin A precursor to prevent blindness, it usually finds a way.
Since bacteria, such as those that cause gonorrhea or gastrointestinal infections, are becoming increasingly resistant to antibiotics, scientists are searching for outside-the-box ideas to tackle the problem. They may have found in one in bacteriophage: viruses that exclusively infect and kill bacteria.
Twelve patients who tried stem cell injections were hospitalized with infections, according to a published report, one that should cause patients concern. More important is that they should investigate stem cell treatments, for conditions such as cartilage injuries to their joints, before committing to one of these procedures.
In 2017, Amazon bought Whole Foods. Amazon's CEO, Jeff Bezos, built his billion-dollar empire on technology. Therefore, you might expect that Whole Foods would become a little friendlier to biotech. But if you did that, you would be wrong.
Telemedicine is a first step towards digitizing the world of medicine, while improving and increasing access to care and reducing out-of-pocket costs.
Despite having yet to save the life of a mouse, an Israeli company is making grandiose pronouncements. However, if you look beyond the hype the medical approach is actually pretty interesting.
It's now possible for your doctor to make house calls, with little more than you using a smartphone and some inexpensive devices. Telemedicine is not just for rural America.
We count on innovation to improve our lives. In a quest to make innovations come faster we have considered how, and to whom, we entrust research and development. A new study suggests that the rate of innovation is driven mostly by how many simple and complex solutions might be available.